Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination.
A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome.
Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases.
Systematic review of clinical practice guidelines related to multiple sclerosis.
Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor.
[Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica : Therapy option for acute relapses during pregnancy and breastfeeding.]
Evaluation of axonal optic nerve damage using visual evoked potentials and optical coherence tomography in patients with multiple sclerosis.
Cucurbitacins attenuate microglial activation and protect from neuroinflammatory injury through Nrf2/ARE activation and STAT/NF-κB inhibition.
L-periaxin interacts with S-periaxin through its PDZ domain.
Tumor necrosis factor-alpha polymorphism and susceptibility to multiple sclerosis in the Iranian population.
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.
Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables.
C9ORF72 repeat expansion not detected in patients with multiple sclerosis.
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
A Patient-defined "Best Case" of Multiple Sclerosis Related to the Use of Complementary and Alternative Medicine.
Role of TRIF Small Interference RNA (siRNA) in Chronic Experimental Allergic Encephalomyelitis (EAE).
Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study.
Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.
Multiple sclerosis and cancer: When two wrongs make a right?
Onset-adjusted incidence of multiple sclerosis in the Girona province (Spain): Evidence of increasing risk in the south of Europe.
IL-25 prevents T cell-mediated neurotoxicity by decreasing LFA-1 expression.
Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis.
Lipid rafts and their possible involvements in neuroimmunological disorders.
LINGO-1 Interacts with the p75 Neurotrophin Receptor in Intracellular Membrane Compartments.
Pages
« first
‹ previous
…
543
544
545
546
547
548
549
550
551
…
next ›
last »